Infusion pump companies are perpetuating misconceptions.
The center will start phasing in efficiencies on March 18.
The strategic acquisitions expand the company’s structural heart disease technologies.
Reparative medicine technology is an option to delay or avoid orthopedic surgery.
The resignation will be effective in about a month, according to reports.
According to the FDA, more than 90% of products sterilized at the facility are medical devices.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
Technologically superior devices, favorable research outcomes and a supportive regulatory structure are fueling growth.
Learn about the new subclass for Class I reusable devices under MDR and the necessary steps to ensure compliance.
The new pump allows patients to customize their diabetes management.